Table 1.
Characteristic | Patients (n = 21) |
---|---|
Age (years) | |
Median (range) | 58 (35–61) |
Sex, no. (%) | |
Male | 17 (81) |
Female | 4 (19) |
ECOG performance status | |
Median (range) | 1 (0–2) |
Stage, no. (%) | |
IIIA | 2 (10) |
IIIC | 2 (10) |
IV | 17 (80) |
Tumor differentiation, no. (%) | |
Well/Moderate | 8 (38) |
Poor | 13 (62) |
Lauren type, no. (%) | |
Diffuse | 4 (19) |
Intestinal | 7 (33) |
Mixed | 10 (48) |
Gastroesophageal junction involvement, no. (%) | |
Yes | 10 (48) |
No | 11 (52) |
Liver involvement, no. (%) | |
Yes | 15 (71) |
No | 6 (28) |
Lung involvement, no. (%) | |
Yes | 10 (48) |
No | 11 (52) |
Prior chemotherapy regimens, no. | |
Median (range) | 0 (0–3) |
Abbreviations: ECOG, Eastern Cooperative Oncology Group